Trait marker IGF1 is more diagnostic than PSA in Ca prostate, study at local population of Karachi

Pakistan Journal of Medical and Health Sciences

Volumn 7, Issue 3, 2013, Pages 626-629

  Iltaf, Muhammed ^a   Jagdesh, ^b   Panjwani, Jai Parkash ^c   Advai, Mukesh Kumar ^d   Memon, Muhammed Yousif ^e   Khalilullah, ^a  

^a JINNAH POSTGRADUATE MEDICAL CENTRE   (Pakistan)

^b Bhitai Dental and Medical College ^*  (Pakistan)

^c BAQAI MEDICAL UNIVERSITY   (Pakistan)

^d Jinnah Postgraduate Medical Cente and Shaheed Mohtarma Benazir Bhutto Medical College   (Pakistan)

^e LIAQUAT UNIVERSITY OF MEDICAL AND HEALTH SCIENCES   (Pakistan)

Author keywords

IGF 1; Prostate cancer; PSA

Indexed keywords

PROSTATE SPECIFIC ANTIGEN; SOMATOMEDIN C;

ADULT; ARTICLE; BIOCHEMISTRY; CANCER DIAGNOSIS; CANCER PATIENT; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; MALE; POPULATION; PROSTATE CANCER; UROLOGY;

EID: 84886051687     PISSN: 19967195     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (8)

1. Saito T, Kitamura Y, Komatsubara S., Matsumoto Y, Sugita T, Hara N. Outcomes of locally advanced prostate cancer: a single institution study of 209 patients in Japan. Asian J Androl 2006; 8: 555-61.).
2. Brawer MK, Cheli CD, Neaman I.E., Goldblatt J., Smith C, Schwartz MK, et al Complexed prostate specific antigen provides significant enhancement of specificity compared with total prostate specific antigen for detecting prostate cancer. J. Urol. 2000; 163:1476-1480.
3. Kurek R, Tunn UW, Eckart O, Aumuller G., Wong J & Rennerberg H. The significance of serum levels of insulin like growth factor-I in patients with prostate cancer. BJU Inter 2000; 85: 125-29.
4. Chan JM, Stampfer MJ, Giovannucci E, Gann P.H., Ma J., Wilkinson P, Hennekens CH & Pollak M. Plasma insulin like growth factor-I and prostate cancer risk: a prospective study. Science 1998; 279: 563-66.
5. Sarma AV, Jaffe CA, Schottenfeld D, Dunn R., Montie JE, Cooney KA, Wei JT Insulin like growth factor-I, Insulin like growth factor binding protein-3 and body mass index: clinical correlates of prostate volume among black men. Urology 2002; 59(3): 362-7.
6. Harman SM, E. Jeffrey Metter, Marc R. Blackman, Patricia K. Landis and H. Ballentine Carter. Serum Levels of Insulin-Like Growth Factor I (IGF-I), IGF-II, IGF-Binding Protein-3, and Prostate-Specific Antigen as Predictors of Clinical Prostate Cancer jcem 2000, 85 (11): 4258
7. Nam RK, Trachtenberg J, Jewett MAS, Toi A, Evans A., Emami M, Narod SA & Pollak M. Serum insulin like growth factor-I levels and intraepithelial neoplasia: a clue to the relationship between IGF-I physiology and prostate cancer risk. Cancer epidemiol biomarkers prev 2005; 14(5): 1270-73
8. Jones JI & Clemmons DR. Insulin like growth factors and their binding proteins: biological actions. Endocrine reviews 1995; 16(1): 3-34.